ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,437.20
      2.12%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.76
      -1.04%
      Bitcoin
      62,999.56
      6.56%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pacira BioSciences Inc (PCRX)

      7. Pacira BioSciences Inc (PCRX) News

      PCRX

      Pacira BioSciences (PCRX)

      Pacira BioSciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PCRX
      DateTimeSourceHeadlineSymbolCompany
      04/30/20248:00AMGlobeNewswire Inc.Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024NASDAQ:PCRXPacira BioSciences Inc
      04/02/20248:00AMGlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
      03/13/20247:00AMGlobeNewswire Inc.Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
      03/06/20248:00AMGlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
      02/29/20243:33PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCRXPacira BioSciences Inc
      02/29/20248:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
      02/29/20248:00AMGlobeNewswire Inc.Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
      02/22/20248:00AMGlobeNewswire Inc.Pacira to Report 2023 Financial Results on Thursday February 29, 2024NASDAQ:PCRXPacira BioSciences Inc
      02/15/20248:36AMGlobeNewswire Inc.Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After BunionectomyNASDAQ:PCRXPacira BioSciences Inc
      02/07/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      02/07/20248:00AMGlobeNewswire Inc.Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.NASDAQ:PCRXPacira BioSciences Inc
      02/01/202410:45AMPR Newswire (US)G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball TeamsNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:18PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
      01/04/20245:00PMGlobeNewswire Inc.Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 RevenuesNASDAQ:PCRXPacira BioSciences Inc
      01/03/20248:00AMGlobeNewswire Inc.Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
      12/21/20237:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
      12/21/20237:30AMGlobeNewswire Inc.Pacira Appoints Frank D. Lee as Chief Executive OfficerNASDAQ:PCRXPacira BioSciences Inc
      12/07/20237:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
      11/13/20239:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
      11/10/20237:30AMGlobeNewswire Inc.Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block IndicationsNASDAQ:PCRXPacira BioSciences Inc
      11/07/20238:00AMGlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in NovemberNASDAQ:PCRXPacira BioSciences Inc
      11/02/20232:59PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
      11/02/20238:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
      11/02/20238:00AMGlobeNewswire Inc.Pacira BioSciences Reports Third Quarter 2023 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
      10/26/20238:00AMGlobeNewswire Inc.Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023NASDAQ:PCRXPacira BioSciences Inc
      10/12/20238:00AMGlobeNewswire Inc.American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.NASDAQ:PCRXPacira BioSciences Inc
       Showing the most relevant articles for your search:NASDAQ:PCRX